Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04897958 · ClinicalTrials.gov registry record
Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 14,417
- Enrollment target
NCT04897958: Completed study, sponsored by Brigham and Women's Hospital.
NCT04897958 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 14,417 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04897958 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 14,417 participants
- Enrollment target
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Primary Outcome
Composite of all-cause mortality, nonfatal MI, and nonfatal stroke
Interventions
- DRUG Degarelix
- DRUG Leuprolide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,417 participants |
| Start Date | 2019-09-21 |
| Est. Completion | 2021-08-01 |
What the finished NCT04897958 record still lists
NCT04897958 is an observational study that tracks outcomes without assigning an intervention. Its 14,417 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Degarelix is the first listed.
NCT04897958 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04897958 about?
NCT04897958 is a clinical study titled "Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04897958?
This trial is currently completed. The enrollment target is 14,417 participants. The study started on 2019-09-21. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT04897958?
The interventions under investigation include: Degarelix (DRUG), Leuprolide (DRUG).
Who is sponsoring clinical trial NCT04897958?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI